This inventor holds 2 USPTO granted patents. Top assignees: Palau Pharma, S.a., Stiefel Laboratories, Inc.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12 
1 out of 34 Years Active: 2011-2012
Title: Antonio Cánovas Paredes: Innovator in Antifungal Compounds
Introduction
Antonio Cánovas Paredes is a prominent inventor located in Tona, Spain, known for his significant contributions to the development of novel antifungal compounds. With a total of two patents to his name, he has made substantial advancements in pharmaceutical compositions aimed at treating microbial and fungal infections.
Latest Patents
Antonio Cánovas Paredes' latest patents focus on crystalline antifungal compounds, specifically novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one. These patents cover pharmaceutical compositions that incorporate these crystalline forms, methods for their usage in treating and preventing various microbial and fungal infections, and the processes involved in obtaining these forms. The specific crystalline forms, labeled I, II, III, IV, V, and VI, underline the innovative approach taken by Paredes in the pharmaceutical field.
Career Highlights
Throughout his career, Antonio has been associated with reputable companies, including Palau Pharma and Stiefel Laboratories, Inc. His work at these organizations has facilitated the advancement of antifungal treatments and has contributed to enhancing public health outcomes.
Collaborations
Collaboration has been a vital aspect of Antonio Cánovas Paredes' career. He has worked alongside esteemed colleagues such as Javier Bartroli Orpi and Elies Molins Grau, contributing to a shared vision of innovation and improvement in pharmaceutical sciences.
Conclusion
Antonio Cánovas Paredes stands as a significant figure in the field of innovation concerning antifungal compounds. His inventions not only reflect his expertise but also his commitment to addressing medical challenges through dedicated research and collaboration. The impact of his work extends toward improving the treatment of fungal infections, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile